(Q39486574)

English

Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

cancer metastasis

1 reference

based on heuristic

inferred from title

Alain Faivre-Chauvet

5

object named as

Alain Faivre-Chauvet

0 references

Patricia Remaud-Le Saëc

object named as

Patricia Remaud-Le Saëc

0 references

object named as

Jacques Barbet

9

0 references

author name string

Eric Frampas

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Catherine Maurel

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Thibault Mauxion

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

François Davodeau

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

David M Goldenberg

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Manuel Bardiès

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jacques Barbet

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

20 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2153-2164

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

https://scigraph.springernature.com/pub.10.1007/s00259-011-1903-0

0 references

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

A voxel-based mouse for internal dose calculations using Monte Carlo simulations (MCNP).

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Glomerular filtration rate after alpha-radioimmunotherapy with 211At-MX35-F(ab')2: a long-term study of renal function in nude mice

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Targeted alpha-therapy: past, present, future?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Carcinoembryonic antigen expression, antibody localisation and immunophotodetection of human colon cancer liver metastases in nude mice: a model for radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1903-0

21 January 2018

Current status and perspectives in alpha radioimmunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of different classes of radionuclides for potential use in radioimmunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow dosimetry for radioimmunotherapy: theoretical considerations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody protein dose and radioimmunodetection of GW-39 human colon tumor xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A universal pretargeting system for cancer detection and therapy using bispecific antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential and limitations of radioimmunodetection and radioimmunotherapy with monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

S-factor calculations for mouse models using Monte-Carlo simulations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21858527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-011-1903-0

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39486574&oldid=1940838836"